Expanding the clinical spectrum of anti-IgLON5 disease: A multicenter retrospective study,European Journal of Neurology

当前位置： X-MOL 学术 › Eur. J. Neurol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Expanding the clinical spectrum of anti-IgLON5 disease: A multicenter retrospective study
European Journal of Neurology ( IF 4.5 ) Pub Date : 2021-09-20 , DOI: 10.1111/ene.15117
You Ni ₁ , Dingding Shen _{1,

2} , Ying Zhang ₃ , Yaying Song ₃ , Yining Gao ₁ , Qinming Zhou ₁ , Lu He ₁ , Dou Yin ₁ , Ying Wang ₄ , Fan Song ₄ , Meiyuan Chen ₅ , Yajun Lian ₆ , Yuan Chen ₆ , Xing Zhao ₇ , Xiang Zhang ₈ , Xiangjun Chen ₈ , Yuting Wang ₉ , Ling Zhang ₁₀ , Nanxun Mo ₁₀ , Dong Lv ₁₁ , Jun Liu ₁ , Zhifeng Mao _{10,

12} , Lisheng Peng ₁₃ , Sheng Chen _{1,

2}

Affiliation

Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Co-innovation Center of Neuroregeneration, Nantong University, Nantong, China.
Department of Neurology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Neurology, The First Affiliated Hospital of Dalian Medical University, Liaoning, China.
Department of Neurology, The Affiliated Hospital of Hangzhou Normal University, Zhejiang, China.
Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Department of Neurology, Guangdong Second Provincial General Hospital, Guangzhou, China.
Department of Neurology, Huashan Hospital and Institute of Neurology, Fudan University, Shanghai, China.
Department of Neurology, Tangshan Gongren Hospital, Hebei, China.
Neuroimmunology Group, KingMed Diagnostic laboratory, Guangzhou, China.
Department of Psychiatry, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Department of Clinical Medicine, Medical School, Xiangnan University, Chenzhou, China.
Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.

We conducted this study to describe detailed the clinical characteristics, ancillary test results and treatment response of a group of Chinese patients with anti-IgLON5 disease.

更新日期：2021-09-20

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11